Different expression of some molecular markers in sporadic cancer of the left and right colon

被引:29
|
作者
Fric, P [1 ]
Sovová, V
Sloncová, E
Lojda, Z
Jirásek, A
Cermák, J
机构
[1] Cent Mil Hosp, Prague 16902 6, Czech Republic
[2] Postgrad Inst Med, Prague 16902 6, Czech Republic
[3] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic
[4] Charles Univ, Lab Histochem, Prague, Czech Republic
[5] Charles Univ, Inst Hematol, Prague, Czech Republic
[6] Charles Univ, Inst Pathol 1, Prague, Czech Republic
[7] Charles Univ, Dept Surg 1, Prague, Czech Republic
关键词
left and right colon; ontogenesis; protooncogenes and DPP IV expression; sporadic cancer;
D O I
10.1097/00008469-200008000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of cytoplasmic c-erbB2, epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and dipeptidylpeptidase IV (DPP IV) was significantly higher in sporadic cancer of the right than of the left colon. In addition, cytoplasmic c-erbB2 displayed the same difference in the adjacent (less than 2 cm) and distant (more than 5 cm from the tumour margin) mucosa. The findings cannot be related to Dukes staging. It is suggested that different ontogenic development of the right (from the midgut) and the left (from the hindgut) colon may be a possible explanation. Therefore, data on the expression of different molecular markers in colorectal cancer and surrounding mucosa should always be supplemented by data on tumour location. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 50 条
  • [1] Different expression of oncogenes and dipeptidylpeptidase IV (DPP IV) in sporadic cancer (CA) of the left and right colon (LC, RC)
    Fric, P
    Sovova, V
    Lojda, Z
    Jirasek, A
    Cermak, J
    GUT, 1997, 41 : A247 - A247
  • [2] The Influence of Clinicopathologic and Molecular Markers on Stage Specific Survival of Right Versus Left Colon Cancer
    Narayanan, S.
    Gabriel, E.
    Attwood, K.
    Nurkin, S.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S76 - S77
  • [3] Development of novel diagnostic and prognostic molecular markers for sporadic colon cancer
    Ahmed, FE
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (03) : 337 - 352
  • [4] Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma -: Different clinical and molecular implications
    Lleonart, ME
    García-Foncillas, J
    Sánchez-Prieto, R
    Martín, P
    Moreno, A
    Salas, C
    Cajal, SR
    CANCER, 1998, 83 (05) : 889 - 895
  • [5] Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer
    Narayanan, Sumana
    Gabriel, Emmanuel
    Attwood, Kristopher
    Boland, Patrick
    Nurkin, Steven
    CLINICAL COLORECTAL CANCER, 2018, 17 (04) : E671 - E678
  • [6] Expression of some molecular biological markers in different histological subtypes of gastric cancer
    Nepomnyashchaya, Evgeniya M.
    Novikova, Inna Arnoldovna
    Ulianova, Elena Petrovna
    Gevorkyan, Yuri
    Dashkov, Andrey
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Molecular analysis of sporadic colon cancer
    Hurtado, Claudia
    Maria Wielandt, Ana
    Zarate, Alejandro J.
    Kronberg, Udo
    Castro, Magdalena
    Yamagiwa, Ken
    Ito, Takashi
    Eishi, Yoshinobu
    Contreras, Luis
    Lopez-Koestner, Francisco
    REVISTA MEDICA DE CHILE, 2015, 143 (03) : 310 - 319
  • [8] Colon cancer: molecular markers
    Arnold, CN
    Blum, HE
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (14) : 880 - 882
  • [9] Right colon cancer - left behind?
    Gervaz, P.
    Usei, M.
    Bouchardy, C.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 8 - 8
  • [10] Right colon cancer: Left behind
    Gervaz, P.
    Usel, M.
    Rapiti, E.
    Chappuis, P.
    Neyroud-Kaspar, I.
    Bouchardy, C.
    EJSO, 2016, 42 (09): : 1343 - 1349